Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke

Background and Purpose: Dual antiplatelet therapy (DAPT), compared to single antiplatelet therapy (SAPT), lowers the risk of stroke or death early after TIA and minor ischemic stroke. Prior trials excluded moderate to severe strokes, due to a potential increased risk of bleeding. We aimed to compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Khazaal, Ossama, Rothstein, Aaron, Husain, Muhammad R., Broderick, Matthew, Cristancho, Daniel, Reyes-Esteves, Sahily, Khan, Farhan, Favilla, Christopher G., Messé, Steven R., Mullen, Michael T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488084/
https://www.ncbi.nlm.nih.gov/pubmed/34616353
http://dx.doi.org/10.3389/fneur.2021.728111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488084/
https://www.ncbi.nlm.nih.gov/pubmed/34616353
http://dx.doi.org/10.3389/fneur.2021.728111

Ejemplares similares